APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Respiratory Virus Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Respiratory Virus Vaccines Industry Growth and Trends Forecast to 2032

31 December 202597 pages

Choose your research edition.

Industry ResearchRespiratory Virus Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Respiratory Virus Vaccines Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Respiratory Virus Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Respiratory Virus Vaccines Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Respiratory Virus Vaccines Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Respiratory Virus Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Respiratory Virus Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Respiratory Virus Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Respiratory Virus Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Respiratory Virus Vaccines include Bharat Biotech, CSL Limited, GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., AstraZeneca, Merck & Co., Inc. and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Respiratory Virus Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Respiratory Virus Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Respiratory Virus Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Respiratory Virus Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Respiratory Virus Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Respiratory Virus Vaccines Market by Company

Bharat Biotech

CSL Limited

GlaxoSmithKline plc

Serum Institute of India Pvt. Ltd.

Sinovac Biotech Ltd.

AstraZeneca

Merck & Co., Inc.

Sanofi

Respiratory Virus Vaccines Segment by Type

Recombinant Vaccines

Inactivated Vaccines

Live-attenuated Vaccines

Respiratory Virus Vaccines Segment by Application

Physician's Office

Pharmacies/Stores

Hospitals

Clinics

Respiratory Virus Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Respiratory Virus Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Respiratory Virus Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Respiratory Virus Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Respiratory Virus Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Respiratory Virus Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Recombinant Vaccines Table 2. Major Company of Inactivated Vaccines Table 3. Major Company of Live-attenuated Vaccines Table 4. Global Respiratory Virus Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Respiratory Virus Vaccines Sales by Type (2021-2026) & (K Units) Table 6. Global Respiratory Virus Vaccines Sales Market Share in Volume by Type (2021-2026) Table 7. Global Respiratory Virus Vaccines Sales by Type (2021-2026) & (US$ Million) Table 8. Global Respiratory Virus Vaccines Sales Market Share in Value by Type (2021-2026) Table 9. Global Respiratory Virus Vaccines Price by Type (2021-2026) & (US$/Unit) Table 10. Global Respiratory Virus Vaccines Sales by Type (2027-2032) & (K Units) Table 11. Global Respiratory Virus Vaccines Sales Market Share in Volume by Type (2027-2032) Table 12. Global Respiratory Virus Vaccines Sales by Type (2027-2032) & (US$ Million) Table 13. Global Respiratory Virus Vaccines Sales Market Share in Value by Type (2027-2032) Table 14. Global Respiratory Virus Vaccines Price by Type (2027-2032) & (US$/Unit) Table 15. North America Respiratory Virus Vaccines Sales by Type (2021-2026) & (K Units) Table 16. North America Respiratory Virus Vaccines Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Respiratory Virus Vaccines Sales by Type (2021-2026) & (K Units) Table 18. Europe Respiratory Virus Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Respiratory Virus Vaccines Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Respiratory Virus Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Respiratory Virus Vaccines Sales by Type (2021-2026) & (K Units) Table 22. Latin America Respiratory Virus Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Respiratory Virus Vaccines Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Respiratory Virus Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Respiratory Virus Vaccines Industry Trends Table 26. Respiratory Virus Vaccines Industry Drivers Table 27. Respiratory Virus Vaccines Industry Opportunities and Challenges Table 28. Respiratory Virus Vaccines Industry Restraints Table 29. Global Respiratory Virus Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Respiratory Virus Vaccines Revenue Market Share by Company (2021-2026) Table 31. Global Respiratory Virus Vaccines Sales by Company (2021-2026) & (K Units) Table 32. Global Respiratory Virus Vaccines Sales Share by Company (2021-2026) Table 33. Global Respiratory Virus Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Respiratory Virus Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Respiratory Virus Vaccines Major Company Production Sites and Headquarters Table 36. Global Respiratory Virus Vaccines Company, Product Type & Application Table 37. Global Respiratory Virus Vaccines Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Respiratory Virus Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Respiratory Virus Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Respiratory Virus Vaccines Sales by Region (2021-2026) & (K Units) Table 42. Global Respiratory Virus Vaccines Sales Market Share in Volume by Region (2021-2026) Table 43. Global Respiratory Virus Vaccines Sales by Region (2021-2026) & (US$ Million) Table 44. Global Respiratory Virus Vaccines Sales Market Share in Value by Region (2021-2026) Table 45. Global Respiratory Virus Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Respiratory Virus Vaccines Sales by Region (2027-2032) & (K Units) Table 47. Global Respiratory Virus Vaccines Sales Market Share in Volume by Region (2027-2032) Table 48. Global Respiratory Virus Vaccines Sales by Region (2027-2032) & (US$ Million) Table 49. Global Respiratory Virus Vaccines Sales Market Share in Value by Region (2027-2032) Table 50. Global Respiratory Virus Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Respiratory Virus Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Respiratory Virus Vaccines Sales by Application (2021-2026) & (K Units) Table 53. Global Respiratory Virus Vaccines Sales Market Share in Volume by Application (2021-2026) Table 54. Global Respiratory Virus Vaccines Sales by Application (2021-2026) & (US$ Million) Table 55. Global Respiratory Virus Vaccines Sales Market Share in Value by Application (2021-2026) Table 56. Global Respiratory Virus Vaccines Price by Application (2021-2026) & (US$/Unit) Table 57. Global Respiratory Virus Vaccines Sales by Application (2027-2032) & (K Units) Table 58. Global Respiratory Virus Vaccines Sales Market Share in Volume by Application (2027-2032) Table 59. Global Respiratory Virus Vaccines Sales by Application (2027-2032) & (US$ Million) Table 60. Global Respiratory Virus Vaccines Sales Market Share in Value by Application (2027-2032) Table 61. Global Respiratory Virus Vaccines Price by Application (2027-2032) & (US$/Unit) Table 62. North America Respiratory Virus Vaccines Sales by Application (2021-2026) & (K Units) Table 63. North America Respiratory Virus Vaccines Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Respiratory Virus Vaccines Sales by Application (2021-2026) & (K Units) Table 65. Europe Respiratory Virus Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Respiratory Virus Vaccines Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Respiratory Virus Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Respiratory Virus Vaccines Sales by Application (2021-2026) & (K Units) Table 69. Latin America Respiratory Virus Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Respiratory Virus Vaccines Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Respiratory Virus Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Bharat Biotech Company Information Table 73. Bharat Biotech Business Overview Table 74. Bharat Biotech Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bharat Biotech Respiratory Virus Vaccines Product Portfolio Table 76. Bharat Biotech Recent Development Table 77. CSL Limited Company Information Table 78. CSL Limited Business Overview Table 79. CSL Limited Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. CSL Limited Respiratory Virus Vaccines Product Portfolio Table 81. CSL Limited Recent Development Table 82. GlaxoSmithKline plc Company Information Table 83. GlaxoSmithKline plc Business Overview Table 84. GlaxoSmithKline plc Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. GlaxoSmithKline plc Respiratory Virus Vaccines Product Portfolio Table 86. GlaxoSmithKline plc Recent Development Table 87. Serum Institute of India Pvt. Ltd. Company Information Table 88. Serum Institute of India Pvt. Ltd. Business Overview Table 89. Serum Institute of India Pvt. Ltd. Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Serum Institute of India Pvt. Ltd. Respiratory Virus Vaccines Product Portfolio Table 91. Serum Institute of India Pvt. Ltd. Recent Development Table 92. Sinovac Biotech Ltd. Company Information Table 93. Sinovac Biotech Ltd. Business Overview Table 94. Sinovac Biotech Ltd. Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sinovac Biotech Ltd. Respiratory Virus Vaccines Product Portfolio Table 96. Sinovac Biotech Ltd. Recent Development Table 97. AstraZeneca Company Information Table 98. AstraZeneca Business Overview Table 99. AstraZeneca Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. AstraZeneca Respiratory Virus Vaccines Product Portfolio Table 101. AstraZeneca Recent Development Table 102. Merck & Co., Inc. Company Information Table 103. Merck & Co., Inc. Business Overview Table 104. Merck & Co., Inc. Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Merck & Co., Inc. Respiratory Virus Vaccines Product Portfolio Table 106. Merck & Co., Inc. Recent Development Table 107. Sanofi Company Information Table 108. Sanofi Business Overview Table 109. Sanofi Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sanofi Respiratory Virus Vaccines Product Portfolio Table 111. Sanofi Recent Development Table 112. North America Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. North America Respiratory Virus Vaccines Sales by Country (2021-2026) & (K Units) Table 114. North America Respiratory Virus Vaccines Sales Market Share by Country (2021-2026) Table 115. North America Respiratory Virus Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 116. North America Respiratory Virus Vaccines Sales Market Share Forecast by Country (2027-2032) Table 117. North America Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Respiratory Virus Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Respiratory Virus Vaccines Market Share by Country (2021-2026) Table 120. North America Respiratory Virus Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Respiratory Virus Vaccines Market Share Forecast by Country (2027-2032) Table 122. Europe Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Europe Respiratory Virus Vaccines Sales by Country (2021-2026) & (K Units) Table 124. Europe Respiratory Virus Vaccines Sales Market Share by Country (2021-2026) Table 125. Europe Respiratory Virus Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 126. Europe Respiratory Virus Vaccines Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Respiratory Virus Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Respiratory Virus Vaccines Market Share by Country (2021-2026) Table 130. Europe Respiratory Virus Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Respiratory Virus Vaccines Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Respiratory Virus Vaccines Sales by Country (2021-2026) & (K Units) Table 134. Asia-Pacific Respiratory Virus Vaccines Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Respiratory Virus Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 136. Asia-Pacific Respiratory Virus Vaccines Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Respiratory Virus Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Respiratory Virus Vaccines Market Share by Country (2021-2026) Table 140. Asia-Pacific Respiratory Virus Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Respiratory Virus Vaccines Market Share Forecast by Country (2027-2032) Table 142. Latin America Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Latin America Respiratory Virus Vaccines Sales by Country (2021-2026) & (K Units) Table 144. Latin America Respiratory Virus Vaccines Sales Market Share by Country (2021-2026) Table 145. Latin America Respiratory Virus Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 146. Latin America Respiratory Virus Vaccines Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Respiratory Virus Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Respiratory Virus Vaccines Market Share by Country (2021-2026) Table 150. Latin America Respiratory Virus Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Respiratory Virus Vaccines Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Respiratory Virus Vaccines Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Respiratory Virus Vaccines Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Respiratory Virus Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 156. Middle East and Africa Respiratory Virus Vaccines Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Respiratory Virus Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Respiratory Virus Vaccines Market Share by Country (2021-2026) Table 160. Middle East and Africa Respiratory Virus Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Respiratory Virus Vaccines Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Respiratory Virus Vaccines Distributors List Table 165. Respiratory Virus Vaccines Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Respiratory Virus Vaccines Image Figure 2. Global Respiratory Virus Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Respiratory Virus Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Respiratory Virus Vaccines Sales (2021-2032) & (K Units) Figure 5. Recombinant Vaccines Image Figure 6. Global Recombinant Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Inactivated Vaccines Image Figure 8. Global Inactivated Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Live-attenuated Vaccines Image Figure 10. Global Live-attenuated Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Respiratory Virus Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Respiratory Virus Vaccines Market Share by Type 2025 VS 2032 Figure 13. North America Respiratory Virus Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. North America Respiratory Virus Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Europe Respiratory Virus Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Europe Respiratory Virus Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Respiratory Virus Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Respiratory Virus Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Latin America Respiratory Virus Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Respiratory Virus Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Respiratory Virus Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Respiratory Virus Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Respiratory Virus Vaccines Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Physician's Office Image Figure 26. Global Physician's Office Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pharmacies/Stores Image Figure 28. Global Pharmacies/Stores Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospitals Image Figure 30. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 31. Clinics Image Figure 32. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Respiratory Virus Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Respiratory Virus Vaccines Market Share by Application 2025 VS 2032 Figure 35. North America Respiratory Virus Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. North America Respiratory Virus Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Europe Respiratory Virus Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Europe Respiratory Virus Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Respiratory Virus Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Respiratory Virus Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Latin America Respiratory Virus Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Respiratory Virus Vaccines Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Respiratory Virus Vaccines Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Respiratory Virus Vaccines Sales Market Share in Value by Application in 2025 Figure 45. North America Respiratory Virus Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Respiratory Virus Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Respiratory Virus Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Respiratory Virus Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Respiratory Virus Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Respiratory Virus Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Respiratory Virus Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Respiratory Virus Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Respiratory Virus Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Respiratory Virus Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Respiratory Virus Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Respiratory Virus Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Respiratory Virus Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Respiratory Virus Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Respiratory Virus Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Respiratory Virus Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Respiratory Virus Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Respiratory Virus Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Respiratory Virus Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Respiratory Virus Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Respiratory Virus Vaccines Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Respiratory Virus Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Inactivated Vaccines
  • Live-attenuated Vaccines
Applications
  • Physician's Office
  • Pharmacies/Stores
  • Hospitals
  • Clinics
Companies covered
  • Bharat Biotech
  • CSL Limited
  • GlaxoSmithKline plc
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • AstraZeneca
  • Merck & Co., Inc.
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Respiratory Virus Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Respiratory Virus Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Respiratory Virus Vaccines Market by Type
  6. 1.3.1 Recombinant Vaccines
  7. 1.3.2 Inactivated Vaccines
  8. 1.3.3 Live-attenuated Vaccines
  9. 1.4 Global Respiratory Virus Vaccines Market Size by Type
  10. 1.4.1 Global Respiratory Virus Vaccines Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Respiratory Virus Vaccines Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Respiratory Virus Vaccines Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Respiratory Virus Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Respiratory Virus Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Respiratory Virus Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Respiratory Virus Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Respiratory Virus Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Respiratory Virus Vaccines Industry Trends
  2. 2.2 Respiratory Virus Vaccines Industry Drivers
  3. 2.3 Respiratory Virus Vaccines Industry Opportunities and Challenges
  4. 2.4 Respiratory Virus Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Respiratory Virus Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Respiratory Virus Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Respiratory Virus Vaccines Price (2021-2026)
  4. 3.4 Global Respiratory Virus Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Respiratory Virus Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Respiratory Virus Vaccines Company, Product Type & Application
  7. 3.7 Global Respiratory Virus Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Respiratory Virus Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Respiratory Virus Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Respiratory Virus Vaccines Tier 1, Tier 2, and Tier 3
4 Respiratory Virus Vaccines Regional Status and Outlook
  1. 4.1 Global Respiratory Virus Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Respiratory Virus Vaccines Historic Market Size by Region
  3. 4.2.1 Global Respiratory Virus Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Respiratory Virus Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Respiratory Virus Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Respiratory Virus Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Respiratory Virus Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Respiratory Virus Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Respiratory Virus Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Respiratory Virus Vaccines by Application
  1. 5.1 Respiratory Virus Vaccines Market by Application
  2. 5.1.1 Physician's Office
  3. 5.1.2 Pharmacies/Stores
  4. 5.1.3 Hospitals
  5. 5.1.4 Clinics
  6. 5.2 Global Respiratory Virus Vaccines Market Size by Application
  7. 5.2.1 Global Respiratory Virus Vaccines Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Respiratory Virus Vaccines Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Respiratory Virus Vaccines Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Respiratory Virus Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Respiratory Virus Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Respiratory Virus Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Respiratory Virus Vaccines Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Respiratory Virus Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bharat Biotech
  2. 6.1.1 Bharat Biotech Company Information
  3. 6.1.2 Bharat Biotech Business Overview
  4. 6.1.3 Bharat Biotech Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bharat Biotech Respiratory Virus Vaccines Product Portfolio
  6. 6.1.5 Bharat Biotech Recent Developments
  7. 6.2 CSL Limited
  8. 6.2.1 CSL Limited Company Information
  9. 6.2.2 CSL Limited Business Overview
  10. 6.2.3 CSL Limited Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSL Limited Respiratory Virus Vaccines Product Portfolio
  12. 6.2.5 CSL Limited Recent Developments
  13. 6.3 GlaxoSmithKline plc
  14. 6.3.1 GlaxoSmithKline plc Company Information
  15. 6.3.2 GlaxoSmithKline plc Business Overview
  16. 6.3.3 GlaxoSmithKline plc Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline plc Respiratory Virus Vaccines Product Portfolio
  18. 6.3.5 GlaxoSmithKline plc Recent Developments
  19. 6.4 Serum Institute of India Pvt. Ltd.
  20. 6.4.1 Serum Institute of India Pvt. Ltd. Company Information
  21. 6.4.2 Serum Institute of India Pvt. Ltd. Business Overview
  22. 6.4.3 Serum Institute of India Pvt. Ltd. Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Serum Institute of India Pvt. Ltd. Respiratory Virus Vaccines Product Portfolio
  24. 6.4.5 Serum Institute of India Pvt. Ltd. Recent Developments
  25. 6.5 Sinovac Biotech Ltd.
  26. 6.5.1 Sinovac Biotech Ltd. Company Information
  27. 6.5.2 Sinovac Biotech Ltd. Business Overview
  28. 6.5.3 Sinovac Biotech Ltd. Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sinovac Biotech Ltd. Respiratory Virus Vaccines Product Portfolio
  30. 6.5.5 Sinovac Biotech Ltd. Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Respiratory Virus Vaccines Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Merck & Co., Inc.
  38. 6.7.1 Merck & Co., Inc. Company Information
  39. 6.7.2 Merck & Co., Inc. Business Overview
  40. 6.7.3 Merck & Co., Inc. Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck & Co., Inc. Respiratory Virus Vaccines Product Portfolio
  42. 6.7.5 Merck & Co., Inc. Recent Developments
  43. 6.8 Sanofi
  44. 6.8.1 Sanofi Company Information
  45. 6.8.2 Sanofi Business Overview
  46. 6.8.3 Sanofi Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sanofi Respiratory Virus Vaccines Product Portfolio
  48. 6.8.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Respiratory Virus Vaccines Sales by Country
  2. 7.1.1 North America Respiratory Virus Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Respiratory Virus Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Respiratory Virus Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Respiratory Virus Vaccines Market Size by Country
  6. 7.2.1 North America Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Respiratory Virus Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Respiratory Virus Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Respiratory Virus Vaccines Sales by Country
  2. 8.1.1 Europe Respiratory Virus Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Respiratory Virus Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Respiratory Virus Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Respiratory Virus Vaccines Market Size by Country
  6. 8.2.1 Europe Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Respiratory Virus Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Respiratory Virus Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Respiratory Virus Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Respiratory Virus Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Respiratory Virus Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Respiratory Virus Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Respiratory Virus Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Respiratory Virus Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Respiratory Virus Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Respiratory Virus Vaccines Sales by Country
  2. 10.1.1 South America Respiratory Virus Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Respiratory Virus Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Respiratory Virus Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Respiratory Virus Vaccines Market Size by Country
  6. 10.2.1 South America Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Respiratory Virus Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Respiratory Virus Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Respiratory Virus Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Respiratory Virus Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Respiratory Virus Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Respiratory Virus Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Respiratory Virus Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Respiratory Virus Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Respiratory Virus Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Respiratory Virus Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Respiratory Virus Vaccines Value Chain Analysis
  2. 12.1.1 Respiratory Virus Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Respiratory Virus Vaccines Production Mode & Process
  7. 12.2 Respiratory Virus Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Respiratory Virus Vaccines Distributors
  10. 12.2.3 Respiratory Virus Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst